Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 9/2005

01-09-2005 | Short Communication

Correlation between “malfunctioning events” and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study

Authors: Elio Castagnola, Giuseppe Fratino, Mariangela Valera, Mareva Giacchino, Riccardo Haupt, Angelo Claudio Molinari

Published in: Supportive Care in Cancer | Issue 9/2005

Login to get access

Abstract

Aim of the study

To evaluate the possible link between malfunctioning events and catheter related infections in indwelling central venous devices in children with cancer.

Patients and methods

Prospective observation of 418 devices inserted in 2 Italian tertiary care pediatric cancer centers. The presence of a relationship was identified if a malfunctioning event was followed by a catheter related infection within 10 days, or vice versa.

Results

The 418 catheters were followed for a period of 107,012 days. Among the malfunctioning events 2 out of 141 (1%) were followed by a catheter related infection while among infectious episodes 3 out of 93 (3%) were followed by a malfunctioning event.

Conclusions

Malfunctioning events followed by catheter related infections and catheter related infections followed by malfunctioning are both rare events in children with cancer.
Literature
1.
Castagnola E, Molinari AC, Fratino G, Viscoli C (2003) Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol 121:233–239PubMed
2.
Crnich CJ, Maki DG (2002) The promise of novel technology for prevention of intravascular device related bloodstream infections. II. Long term devices. Clin Infect Dis 34:1362–1368
3.
Darouiche RO (2001) Device associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 33:1567–1572
4.
De Pauw B, Meunier F (2000) Infections in patients with acute leukemia and lymphoma. In: Mandell GL, Bennett JB, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3090–3102
5.
Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387–1393
6.
Fratino G, Mazzola C, Buffa P, Torre M, Castagnola E, Magillo P et al (2001) Mechanical complications related to indwelling central venous catheter in hematology/oncology patients. Pediatr Hematol Oncol 18:317–324
7.
Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R (2005) Central venous catheter related complications in children with oncological/hematological diseases: an observational study on 418 devices. Ann Oncol. [Epub ahead of print]
8.
Journeycake JM, Buchanan GR (2003) Thrombotic complications of central venous catheters in children. Curr Opin Hematol 10:369–374
9.
Mermel LA (2000) Prevention of intravascular catheter related infections. Ann Intern Med 132:391–402PubMed
10.
Molinari AC, Castagnola E, Mazzola C, Piacentino M, Fratino G (2001) Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study on 362 catheters. Support Care Cancer 9:539–544CrossRefPubMed
11.
O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Dennis G, Maki DG et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35:1281–1307CrossRef
12.
Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP (1994) The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:1014–1016
13.
Tolar B, Gould JR (1996) The timing and sequence of multiple device related complications in patients with long term indwelling Groshong catheters. Cancer 78:1308–1313
14.
Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F et al (1999) Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group Infectious Diseases Section. Eur J Cancer 35:770–774CrossRefPubMed
Metadata
Title
Correlation between “malfunctioning events” and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study
Authors
Elio Castagnola
Giuseppe Fratino
Mariangela Valera
Mareva Giacchino
Riccardo Haupt
Angelo Claudio Molinari
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0802-y

Other articles of this Issue 9/2005

Supportive Care in Cancer 9/2005 Go to the issue

Original Article

Another form to fill in! Clients’ reflections on the hospice use of questionnaires

Original Article

Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain

Original Article

Nurses’ willingness to maximize opioid analgesia for severe cancer pain, and its predictor

Original Article

Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study

Editorial

CAM for cancer?

Original Article

An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits